| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA151451
Max Phase: Preclinical
Molecular Formula: C25H20N6
Molecular Weight: 404.48
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1c(CNc2ccc3c4c(cccc24)-c2ccccc2-3)cnc2nc(N)nc(N)c12
Standard InChI: InChI=1S/C25H20N6/c1-13-14(12-29-24-21(13)23(26)30-25(27)31-24)11-28-20-10-9-18-16-6-3-2-5-15(16)17-7-4-8-19(20)22(17)18/h2-10,12,28H,11H2,1H3,(H4,26,27,29,30,31)
Standard InChI Key: UYPDILOOFRURAA-UHFFFAOYSA-N
Associated Targets(Human)
Dihydrofolate reductase 3072 Activities
Associated Targets(non-human)
Dihydrofolate reductase 350 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 404.48 | Molecular Weight (Monoisotopic): 404.1749 | AlogP: 4.91 | #Rotatable Bonds: 3 |
| Polar Surface Area: 102.74 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 3.27 | CX LogP: 4.17 | CX LogD: 4.17 |
| Aromatic Rings: 5 | Heavy Atoms: 31 | QED Weighted: 0.39 | Np Likeness Score: -0.68 |
References
| 1. Debnath AK.. (2002) Pharmacophore mapping of a series of 2,4-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex dihydrofolate reductase., 45 (1): [PMID:11754578] [10.1021/jm010360c] |
Source
Source(1):